Predictive Oncology Inc (POAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 240 | 364 | 456 | 372 | 315 |
| Cost of Goods | 120 | 153 | 108 | 134 | 109 |
| Gross Profit | 120 | 210 | 348 | 238 | 205 |
| Operating Expenses | 3,705 | 8,327 | 4,587 | 10,897 | 3,729 |
| Operating Income | -3,465 | -7,963 | -4,131 | -10,525 | -3,414 |
| Other Income | 43 | 47 | 71 | 134 | 43 |
| Pre-tax Income | -3,422 | -7,916 | -4,060 | -10,391 | -3,371 |
| Net Income Continuous | -3,422 | -7,916 | -4,060 | -10,391 | -3,371 |
| Net Income | $-3,422 | $-7,916 | $-4,060 | $-10,391 | $-3,371 |
| EPS Basic Total Ops | -12.89 | -30.43 | -15.59 | -43.33 | -15.29 |
| EPS Basic Continuous Ops | -12.93 | -30.41 | -15.53 | -43.40 | -15.35 |
| EPS Diluted Total Ops | -12.89 | -30.43 | -15.59 | -43.33 | -15.29 |
| EPS Diluted Continuous Ops | -12.93 | -30.41 | -15.53 | -43.40 | -15.35 |
| EBITDA(a) | $-3,227 | $-11,513 | $3,431 | $-10,200 | $-3,091 |